Aspirin in the prevention of strokes

Biomedicine and Pharmacotherapy

Volumn 53, Issue 7, 1999, Pages 309-311

  Diener, H C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Aspirin; Hemorrhage; Secondary prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; PLACEBO; TICLOPIDINE;

BLEEDING; CEREBROVASCULAR ACCIDENT; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0033178021     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)88501-7     Document Type: Article

References (31)

1. A Swedish cooperative study. High dose acetylsalicylic acid after cerebral infarction. Stroke 1987; 18 : 325-34.
2. Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996; 60 : 197-9.
3. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999; 65 : 255.
4. Anti-platelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged anti-platelet treatment. Br Med J 1988; 296 : 320-31.
5. Anti-platelet Trialists Collaboration. Collaborative overview of randomized trials of anti-platelet therapy 1: Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients. Br Med J 1994; 308 : 81-106.
6. Barnett HJ, Taylor DVV, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339 : 11415-25.
7. Bousser MG, Eschwege E, Haguenau M, Lefaucconier JM, Thibuit N, Touboul D, et al. 'AICL': A controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983; 13 : 5-14.
8. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299 : 53-9.
9. Caprie Steering Committee. A randomized, blinded, trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet 1996; 348 : 1329-39.
10. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: A randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997; 349 : 1641-9.
11. Department of Health and Human Services, Food and Drug Administration. Internal analgesic, anti-pyretic, and anti-rheumatic drug products for over-the-counter human use. Final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. Federal Register 1998; 63 : 56802-19.
12. Diener HC. The use of acetylsalicyclic acid in the secondary prevention of stroke. Int J Clin Practice 1998; 97 : 12-5.
13. Diener HQ Cuhna L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143 : 1-13.
14. Dyken ML. Controversies in stroke: Past and present. The Willis lecture. Stroke 1993; 24 : 1251-8.
15. Dyken ML, Barnett HJM, Easton JD, Fields WS, Fuster V, Hachsinski V, et al. Low dose aspirin and stroke. 'It ain't necessarily so'. Stroke 1991; 23 : 1395-9.
16. EAFT Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342 : 1255-62.
17. European Carotid Surgery Trialists' Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European carotid surgery trial. Lancet 1996; 347 : 1591-3.
18. European Carotid Surgery Trialists' Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351 : 1379-87.
19. Fields WS, Lemak N, Frankowski F, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Part II. Stroke 1978; 9 : 309-19.
20. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8 : 301-16.
21. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; i : 1215-20.
22. Guiraud-Chaumeil B, Rascol A, David J, Borieu B, Clanet M, Bierme R. Prevention des récidives des accidents vasculaires cérebraux ischémiques par les anti-agrégants plaquettaires. Rev Neurol 1982; 138 ; 367-85.
23. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke. N Engl J Med 1989; 321 : 501-7.
24. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997; 349 : 1564-5.
25. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325 : 445-53.
26. Patrono C, Roth GJ. Aspirin in ischemic cerebrovascular disease. Stroke 1996; 27 : 756-60.
27. Reuther RD. Aspirin in patients with cerebral ischemia and normal angiograms or non-surgical lesions. In: Breddin KD, Loew VV, Marx D, eds. Acetylsalicylic Acid in Cerebral Ischemia and Coronary Heart Disease. Stuttgart: Schattauer; 1978. p. 97-106.
28. Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke 1983; 14 : 15-22.
29. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325 : 1261-6.
30. The SALT Collaborative Group. Swedish Aspirin Low Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338 : 1345-9.
31. UK TIA Study Group. The United Kingdom Transient Ischaemic Attack (UK TIA) aspirin trial., final results. J Neurol Neurosurg Psychiatry 1991; 54 : 1044-54.